1-12 of 12
Wendy B. London
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Long-Term Follow-up of a Phase III Study of ch14.18 (Dinutuximab) + Cytokine Immunotherapy in Children with High-Risk Neuroblastoma: COG Study ANBL0032

Available to Purchase
Alice L. Yu, Andrew L. Gilman, M. Fevzi Ozkaynak, Arlene Naranjo, Mitchell B. Diccianni, Jacek Gan, Jacquelyn A. Hank, Ayse Batova, Wendy B. London, Sheena C. Tenney, Malcolm Smith, Barry L. Shulkin, Marguerite Parisi, Katherine K. Matthay, Susan L. Cohn, John M. Maris, Rochelle Bagatell, Julie R. Park, Paul M. Sondel
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (8): 2179–2189.
https://doi.org/10.1158/1078-0432.CCR-20-3909
Published: 15 April 2021
View articletitled, Long-Term Follow-up of a Phase III Study of ch14.18 (Dinutuximab) + Cytokine Immunotherapy in Children with High-Risk Neuroblastoma: COG Study ANBL0032
Open the PDF for Long-Term Follow-up of a Phase III Study of ch14.18 (Dinutuximab) + Cytokine Immunotherapy in Children with High-Risk Neuroblastoma: COG Study ANBL0032 in another window
Includes: Supplementary data
Journal Articles

Antitumor Activity and Tolerability of hu14.18-IL2 with GMCSF and Isotretinoin in Recurrent or Refractory Neuroblastoma: A Children's Oncology Group Phase II Study

Available to Purchase
Suzanne Shusterman, Arlene Naranjo, Collin Van Ryn, Jaquelyn A. Hank, Marguerite T. Parisi, Barry L. Shulkin, Sabah Servaes, Wendy B. London, Hiroyuki Shimada, Jacek Gan, Steven D. Gillies, John M. Maris, Julie R. Park, Paul M. Sondel
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (20): 6044–6051.
https://doi.org/10.1158/1078-0432.CCR-19-0798
Published: 15 October 2019
View articletitled, Antitumor Activity and Tolerability of hu14.18-IL2 with GMCSF and Isotretinoin in Recurrent or Refractory Neuroblastoma: A Children's Oncology Group Phase II Study
Open the PDF for Antitumor Activity and Tolerability of hu14.18-IL2 with GMCSF and Isotretinoin in Recurrent or Refractory Neuroblastoma: A Children's Oncology Group Phase II Study in another window
Journal Articles

Neuroblastoma Patients' KIR and KIR-Ligand Genotypes Influence Clinical Outcome for Dinutuximab-based Immunotherapy: A Report from the Children's Oncology Group

Free
Amy K. Erbe, Wei Wang, Lakeesha Carmichael, KyungMann Kim, Eneida A. Mendonça, Yiqiang Song, Dustin Hess, Patrick K. Reville, Wendy B. London, Arlene Naranjo, Jacquelyn A. Hank, Mitchell B. Diccianni, Ralph A. Reisfeld, Stephen D. Gillies, Katherine K. Matthay, Susan L. Cohn, Michael D. Hogarty, John M. Maris, Julie R. Park, M. Fevzi Ozkaynak, Andrew L. Gilman, Alice L. Yu, Paul M. Sondel
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2018) 24 (1): 189–196.
https://doi.org/10.1158/1078-0432.CCR-17-1767
Published: 02 January 2018
View articletitled, Neuroblastoma Patients' KIR and KIR-Ligand Genotypes Influence Clinical Outcome for Dinutuximab-based Immunotherapy: A Report from the Children's Oncology Group
Open the PDF for Neuroblastoma Patients' KIR and KIR-Ligand Genotypes Influence Clinical Outcome for Dinutuximab-based Immunotherapy: A Report from the Children's Oncology Group in another window
Includes: Supplementary data
Journal Articles

Clinicopathologic Features and Long-term Outcomes of NUT Midline Carcinoma

Available to Purchase
Daniel E. Bauer, Chelsey M. Mitchell, Kelly M. Strait, Christopher S. Lathan, Edward B. Stelow, Sonja C. Lüer, Somala Muhammed, Andrew G. Evans, Lynette M. Sholl, Juan Rosai, Eugenia Giraldi, Richard P. Oakley, Carlos Rodriguez-Galindo, Wendy B. London, Stephen E. Sallan, James E. Bradner, Christopher A. French
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (20): 5773–5779.
https://doi.org/10.1158/1078-0432.CCR-12-1153
Published: 14 October 2012
View articletitled, Clinicopathologic Features and Long-term Outcomes of NUT Midline Carcinoma
Open the PDF for Clinicopathologic Features and Long-term Outcomes of NUT Midline Carcinoma in another window
Includes: Supplementary data
Journal Articles

Mechanisms of CHD5 Inactivation in Neuroblastomas

Available to Purchase
Hiroshi Koyama, Tiangang Zhuang, Jennifer E. Light, Venkatadri Kolla, Mayumi Higashi, Patrick W. McGrady, Wendy B. London, Garrett M. Brodeur
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (6): 1588–1597.
https://doi.org/10.1158/1078-0432.CCR-11-2644
Published: 14 March 2012
View articletitled, Mechanisms of CHD5 Inactivation in Neuroblastomas
Open the PDF for Mechanisms of CHD5 Inactivation in Neuroblastomas in another window
Journal Articles

miRNA Expression Profiling Enables Risk Stratification in Archived and Fresh Neuroblastoma Tumor Samples

Available to Purchase
Katleen De Preter, Pieter Mestdagh, Joëlle Vermeulen, Fjoralba Zeka, Arlene Naranjo, Isabella Bray, Victoria Castel, Caifu Chen, Elzbieta Drozynska, Angelika Eggert, Michael D. Hogarty, Ewa Iżycka-Swieszewska, Wendy B. London, Rosa Noguera, Marta Piqueras, Kenneth Bryan, Benjamin Schowe, Peter van Sluis, Jan J. Molenaar, Alexander Schramm, Johannes H. Schulte, Raymond L. Stallings, Rogier Versteeg, Geneviève Laureys, Nadine Van Roy, Frank Speleman, Jo Vandesompele
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (24): 7684–7692.
https://doi.org/10.1158/1078-0432.CCR-11-0610
Published: 18 December 2011
View articletitled, miRNA Expression Profiling Enables Risk Stratification in Archived and Fresh Neuroblastoma Tumor Samples
Open the PDF for miRNA Expression Profiling Enables Risk Stratification in Archived and Fresh Neuroblastoma Tumor Samples in another window
Includes: Supplementary data
Journal Articles

Phase II Study of Oral Capsular 4-Hydroxyphenylretinamide (4-HPR/Fenretinide) in Pediatric Patients with Refractory or Recurrent Neuroblastoma: A Report from the Children's Oncology Group

Available to Purchase
Judith G. Villablanca, Wendy B. London, Arlene Naranjo, Patrick McGrady, Matthew M. Ames, Joel M. Reid, Renee M. McGovern, Sarah A. Buhrow, Hollie Jackson, Enno Stranzinger, Brenda J. Kitchen, Paul M. Sondel, Marguerite T. Parisi, Barry Shulkin, Gregory A. Yanik, Susan L. Cohn, C. Patrick Reynolds
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (21): 6858–6866.
https://doi.org/10.1158/1078-0432.CCR-11-0995
Published: 31 October 2011
View articletitled, Phase II Study of Oral Capsular 4-Hydroxyphenylretinamide (4-HPR/Fenretinide) in Pediatric Patients with Refractory or Recurrent Neuroblastoma: A Report from the Children's Oncology Group
Open the PDF for Phase II Study of Oral Capsular 4-Hydroxyphenylretinamide (4-HPR/Fenretinide) in Pediatric Patients with Refractory or Recurrent Neuroblastoma: A Report from the Children's Oncology Group in another window
Journal Articles

Prognostic Significance of Interleukin-6 Single Nucleotide Polymorphism Genotypes in Neuroblastoma: rs1800795 (Promoter) and rs8192284 (Receptor)

Available to Purchase
Joanne P. Lagmay, Wendy B. London, Thomas G. Gross, Amanda Termuhlen, Nicholas Sullivan, Amy Axel, Bethany Mundy, Mark Ranalli, Jason Canner, Patrick McGrady, Brett Hall
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (16): 5234–5239.
https://doi.org/10.1158/1078-0432.CCR-08-2953
Published: 12 August 2009
View articletitled, Prognostic Significance of Interleukin-6 Single Nucleotide Polymorphism Genotypes in Neuroblastoma: rs1800795 (Promoter) and rs8192284 (Receptor)
Open the PDF for Prognostic Significance of Interleukin-6 Single Nucleotide Polymorphism Genotypes in Neuroblastoma: rs1800795 (Promoter) and rs8192284 (Receptor) in another window
Journal Articles

Focal Adhesion Kinase Expression in Human Neuroblastoma: Immunohistochemical and Real-time PCR Analyses

Available to Purchase
Elizabeth A. Beierle, Nicole A. Massoll, Joseph Hartwich, Elena V. Kurenova, Vita M. Golubovskaya, William G. Cance, Patrick McGrady, Wendy B. London
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (11): 3299–3305.
https://doi.org/10.1158/1078-0432.CCR-07-1511
Published: 02 June 2008
View articletitled, Focal Adhesion Kinase Expression in Human Neuroblastoma: Immunohistochemical and Real-time PCR Analyses
Open the PDF for Focal Adhesion Kinase Expression in Human Neuroblastoma: Immunohistochemical and Real-time PCR Analyses in another window
Journal Articles

Methylation of CASP8, DCR2, and HIN-1 in Neuroblastoma Is Associated with Poor Outcome

Available to Purchase
Qiwei Yang, Colleen M. Kiernan, Yufeng Tian, Helen R. Salwen, Alexandre Chlenski, Babette A. Brumback, Wendy B. London, Susan L. Cohn
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (11): 3191–3197.
https://doi.org/10.1158/1078-0432.CCR-06-2846
Published: 01 June 2007
View articletitled, Methylation of CASP8, DCR2, and HIN-1 in Neuroblastoma Is Associated with Poor Outcome
Open the PDF for Methylation of CASP8, DCR2, and HIN-1 in Neuroblastoma Is Associated with Poor Outcome in another window
Journal Articles

Does MYCN Amplification Manifested as Homogeneously Staining Regions at Diagnosis Predict a Worse Outcome in Children with Neuroblastoma? A Children's Oncology Group Study

Available to Purchase
Lisa A. Moreau, Patrick McGrady, Wendy B. London, Hiroyuki Shimada, Susan L. Cohn, John M. Maris, Lisa Diller, A. Thomas Look, Rani E. George
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (19): 5693–5697.
https://doi.org/10.1158/1078-0432.CCR-06-1500
Published: 04 October 2006
View articletitled, Does MYCN Amplification Manifested as Homogeneously Staining Regions at Diagnosis Predict a Worse Outcome in Children with Neuroblastoma? A Children's Oncology Group Study
Open the PDF for Does MYCN Amplification Manifested as Homogeneously Staining Regions at Diagnosis Predict a Worse Outcome in Children with Neuroblastoma? A Children's Oncology Group Study in another window
Journal Articles

p16/p14ARF Cell Cycle Regulatory Pathways in Primary Neuroblastoma: p16 Expression Is Associated with Advanced Stage Disease

Available to Purchase
Motoko Omura-Minamisawa, Mitchell B. Diccianni, Ray C. Chang, Ayse Batova, Louis J. Bridgeman, Jessica Schiff, Susan L. Cohn, Wendy B. London, Alice L. Yu
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (11): 3481–3490.
Published: 01 November 2001
View articletitled, p16/p14ARF Cell Cycle Regulatory Pathways in Primary Neuroblastoma: p16 Expression Is Associated with Advanced Stage Disease
Open the PDF for p16/p14ARF Cell Cycle Regulatory Pathways in Primary Neuroblastoma: p16 Expression Is Associated with Advanced Stage Disease in another window